e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry
Vanessa Martelli, Jenna Sykes, Pierre-Régis Burgel, Gil Bellis, Adèle Coriati, Sanja Stanojevic, Anne Louise Stephenson
Source:
Eur Respir J, 55 (1) 1901667; 10.1183/13993003.01667-2019
Journal Issue:
January
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vanessa Martelli, Jenna Sykes, Pierre-Régis Burgel, Gil Bellis, Adèle Coriati, Sanja Stanojevic, Anne Louise Stephenson. Validation of short- and long-term demographic forecasts using the Canadian Cystic Fibrosis Registry. Eur Respir J, 55 (1) 1901667; 10.1183/13993003.01667-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Year: 2017
Clinical, functional and microbiological characteristics of an adult brazilian cystic fibrosis population
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
Cardiorespiratory Fitness in an adult Norwegian Cystic Fibrosis Population
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN): structure and impact since 2009
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
Development of pediatric cross-cultural patient-reported outcome measures: QOL-PCD
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014
Baseline characteristics of 1461 participants in the Pulmonary Fibrosis Foundation Patient Registry
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
The Severe Asthma Registry – German data
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
The Latin American Idiopathic Pulmonary Fibrosis Registry (REFIPI): Baseline Characteristics
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Post-Tuberculosis Bronchiectasis in India:Outcomes of the Indian EMBARC Registry
Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Year: 2018
Lung function decline and outcomes in an elderly population: findings from the Cardiovascular Health Study
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
Comparative Evaluation of Clinical, Spiro/Oscillometric and Tomographic Parameters As A Global Assessment of Children With Cystic Fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Collaboration between the Russian National CF Patient Registry and the European CF Society Patient Registry
Source: International Congress 2018 – Russian Speaking Programme 2018: Part I
Year: 2018
ISHLT Registry Data and Country Registries: Comparison of reported European Lung Transplant Activities in 2016
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
First analysis of the Severe Paediatric Asthma Collaborative in Europe registry
Source: ERJ Open Res, 6 (4) 00566-2020; 10.1183/23120541.00566-2020
Year: 2020
A review of Lung Transplantation for Cystic Fibrosis in Ireland in 2017.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept